SCHEMBL30889702

SCHEMBL30889702

Cc1ccc2oc(-c3ccn[nH]3)c(C)c(=O)c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.46
CSNK2A2 P19784 5/20 0.45
CSNK2B P67870 5/20 0.45
CSNK2A1 P68400 5/20 0.45
MAPT P10636 8/20 0.45
KDM4E B2RXH2 6/20 0.45
SMN1; SMN2 Q16637 5/20 0.43
TP53 P04637 4/20 0.43
ALDH1A1 P00352 4/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
HPGD P15428 3/20 0.43
MEN1 O00255 2/20 0.43
HTT P42858 1/20 0.43
ALPG P10696 1/20 0.41
RXFP1 Q9HBX9 2/20 0.40
AKR1B1 P15121 1/20 0.40
POLB P06746 1/20 0.40
CYP3A4 P08684 1/20 0.40
CASP1 P29466 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31316450 0.73 MAPT (0.74) KMT2ACSNK2A2CSNK2BCSNK2A1MAPT
SCHEMBL29171535 0.73 MAPT (0.74) KMT2ACSNK2A2CSNK2BCSNK2A1MAPT
SCHEMBL30742014 0.72 KMT2A (0.54) KMT2ACSNK2A2CSNK2BCSNK2A1MAPT
SCHEMBL1611070 0.70 ALPG (0.59) KMT2ACSNK2A2CSNK2BCSNK2A1MAPT
SCHEMBL30742511 0.69 MAPT (0.53) KMT2ACSNK2A2CSNK2BCSNK2A1MAPT
SCHEMBL30742368 0.68 KMT2A (0.47) KMT2ACSNK2A2CSNK2BCSNK2A1MAPT
SCHEMBL6471093 0.68 ALPG (0.67) KMT2ACSNK2A2CSNK2BCSNK2A1MAPT
SCHEMBL31035264 0.67 ALPG (0.49) KMT2ACSNK2A2CSNK2BCSNK2A1MAPT
SCHEMBL30928529 0.67 MAPT (0.41) KMT2ACSNK2A2CSNK2BCSNK2A1MAPT
SCHEMBL6646356 0.67 AKR1B1 (0.59) KMT2AMAPTKDM4ETP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4611899-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE Petra Pharma Corporation (US) 2025-09-10 EP disclosed
WO-2024097172-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE PETRA PHARMA CORPORATION (US) 2024-05-10 WO disclosed